Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’

Focused chemists in lab coats and safety goggles making experiments.

Scientists at St. Jude Children’s Research Hospital are reporting the most comprehensive study to date describing the variations in drug response across different genetic subtypes of acute lymphoblastic leukemia (ALL). The findings provide a blueprint for precision medicine to further individualize therapy. The study was published today in Nature Medicine.

Treatment for combat-related PTSD advances with method shown to be fast, effective

Previous article

New approach successfully traces genomic variants back to genetic disorders

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations